{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:29Z","timestamp":1772166149512,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["2016\/IV\/56MN"],"award-info":[{"award-number":["2016\/IV\/56MN"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["2016\/X\/9SZB"],"award-info":[{"award-number":["2016\/X\/9SZB"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Familial hypercholesterolemia (FH) increases the risk of atherosclerosis in children and adults. Atherosclerotic cardiovascular disease in young patients FH is usually subclinical but recognition of children with more pronounced changes is crucial for adjusting effective management. Aim of this research was to use ultrasonography with two-dimensional speckle tracking (2DST) and tonometry to evaluate atherosclerotic changes in patients with FH (parents and their offspring).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Applanation tonometry and carotid arteries sonography with evaluation of the intima-media complex thickness (IMCT) and application of the 2DST were performed in 20 families with FH (20 parents and 29 children). The same size control group (age and sex matched) was included. Results were compared between peers and between generations together with the correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Adults with FH, in comparison with healthy peers, presented significantly more atherosclerotic plaques (9 vs. 2,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0230), had significantly thicker IMC (0.84\u2009\u00b1\u20090.19 vs. 0.56\u2009\u00b1\u20090.06\u2009mm,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and had stiffer arterial wall (for stain: 6.25\u2009\u00b1\u20092.3 vs. 8.15\u2009\u00b1\u20092.46,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0103). In children from both groups there were no atherosclerotic plaques and IMCT did not differ significantly (0.42\u2009\u00b1\u20090.07 vs. 0.39\u2009\u00b1\u20090.04,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.1722). However, children with FH had significantly stiffer arterial wall according to 2DST (for strain: 9.22\u2009\u00b1\u20093.4 vs. 11.93\u2009\u00b1\u20093.11,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0057) and tonometry (for the pulse wave velocity: 4.5\u2009\u00b1\u20090.64 vs.3.96\u2009\u00b1\u20090.62,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0047). These parameters correlated with atherosclerosis surrogates in their parents (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) but were not significantly affected by presence of presumed pathogenic gene variant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children with FH presented subclinical atherosclerosis manifested as decreased arterial wall elasticity. Degree of stiffening was associated with advancement of atherosclerosis in their parents but did not present significant association with gene variants. Sonography with application of 2DST seems to be a good candidate for comprehensive evaluation of atherosclerosis in families with FH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-020-01335-2","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T11:03:52Z","timestamp":1594724632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["\u201cApple does not fall far from the tree\u201d \u2013 subclinical atherosclerosis in children with familial hypercholesterolemia"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4513-0602","authenticated-orcid":false,"given":"Micha\u0142","family":"Podg\u00f3rski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Szatko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Sta\u0144czyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Pawlak-Bratkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Konopka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Starostecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Tkaczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"G\u00f3reczny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Gach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"\u0141ukaszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Grzelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2010.11.005","volume":"214","author":"H Mabuchi","year":"2011","unstructured":"Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, et al. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011;214:404\u20137.","journal-title":"Atherosclerosis."},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1001\/jama.290.17.2271","volume":"290","author":"S Li","year":"2003","unstructured":"Li S, Chen W, Srinivasan SR, Bond MG, Tang R, et al. Childhood cardiovascular risk factors intima and carotid vascular changes in adulthood: the Bogalusa heart study. JAMA. 2003;290:2271\u20136.","journal-title":"JAMA."},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/01.ATV.13.9.1291","volume":"13","author":"Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","year":"1993","unstructured":"Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Arterioscler Thromb. 1993;13:1291\u20138.","journal-title":"Arterioscler Thromb"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacl.2014.01.001","volume":"8","author":"M My\u015bliwiec","year":"2014","unstructured":"My\u015bliwiec M, Walczak M, Ma\u0142ecka-Tendera E, Dobrza\u0144ska A, Cybulska B, et al. Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum. J Clin Lipidol. 2014;8:173\u201380.","journal-title":"J Clin Lipidol"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.5551\/jat.CR002","volume":"25","author":"M Harada-Shiba","year":"2018","unstructured":"Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, et al. Guidance for pediatric Familial hypercholesterolemia 2017. J Atheroscler Thromb. 2018;25:539\u201353. https:\/\/doi.org\/10.5551\/jat.CR002.","journal-title":"J Atheroscler Thromb"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2337\/dc10-0505","volume":"33","author":"HD Margeirsdottir","year":"2010","unstructured":"Margeirsdottir HD, Stensaeth KH, Larsen JR, Brunborg C, Dahl-Jorgensen K. Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study. Diabetes Care. 2010;33:2043\u20138.","journal-title":"Diabetes Care"},{"key":"1335_CR7","first-page":"SC01","volume":"11","author":"N Rostampour","year":"2017","unstructured":"Rostampour N, Fekri K, Hashemi-Dehkordi E, Obodiat M. Association between vascular endothelial markers and carotid intima-media thickness in children and adolescents with type 1 diabetes mellitus. J Clin Diagn Res. 2017;11:SC01\u20135.","journal-title":"J Clin Diagn Res"},{"key":"1335_CR8","first-page":"1462","volume":"28","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462\u2013536.","journal-title":"Eur Heart J"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5114\/aoms.2015.49205","volume":"11","author":"M Podg\u00f3rski","year":"2015","unstructured":"Podg\u00f3rski M, Grzelak P, Szymczyk K, Szymczyk E, Dro\u017cd\u017c J, et al. Peripheral vascular stiffness, assessed with two-dimensional speckle tracking versus the degree of coronary artery calcification, evaluated by tomographic coronary artery calcification index. Arch Med Sci. 2015;11:122\u20139.","journal-title":"Arch Med Sci"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1708538117720047","volume":"26","author":"M Podg\u00f3rski","year":"2018","unstructured":"Podg\u00f3rski M, Grzelak P, Kaczmarska M, Polguj M, \u0141ukaszewski M, et al. Feasibility of two-dimensional speckle tracking in evaluation of arterial stiffness: comparison with pulse wave velocity and conventional sonographic markers of atherosclerosis. Vascular. 2018;26:63\u20139.","journal-title":"Vascular."},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.12659\/MSM.916466","volume":"28","author":"M Podg\u00f3rski","year":"2019","unstructured":"Podg\u00f3rski M, Szatko K, Sta\u0144czyk M, Pawlak-Bratkowska M, Fila M, et al. Two-Dimensional Speckle Tracking Versus Applanation Tonometry in Evaluation of Subclinical Atherosclerosis in Children with Type 1 Diabetes Mellitus. Med Sci Monit. 2019;28:7289\u201394. https:\/\/doi.org\/10.12659\/MSM.916466.","journal-title":"Med Sci Monit"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2019.06.899","volume":"288","author":"K Dyrbu\u015b","year":"2019","unstructured":"Dyrbu\u015b K, G\u0105sior M, Desperak P, Osadnik T, Nowak J, Banach M. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the polish tertiary Centre: results from the TERCET registry with 19,781 individuals. Atherosclerosis. 2019;288:33\u201341.","journal-title":"Atherosclerosis."},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1194\/jlr.S074039","volume":"58","author":"AC Martin","year":"2017","unstructured":"Martin AC, Gidding SS, Wiegman A, Watts GF. Knowns and unknowns in the care of pediatric familial hypercholesterolemia. J Lipid Res. 2017;58:1765\u201376. https:\/\/doi.org\/10.1194\/jlr.S074039.","journal-title":"J Lipid Res"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2018.08.051","volume":"277","author":"AJ Vallejo-Vaz","year":"2018","unstructured":"EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, De Marco M, CAT S, Akram A, et al. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - the EAS Familial Hypercholesterolaemia studies collaboration (FHSC). Atherosclerosis. 2018;277:234\u201355. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.051.","journal-title":"Atherosclerosis."},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","volume":"21","author":"A Wiegman","year":"2015","unstructured":"Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;21:2425\u201337. https:\/\/doi.org\/10.1093\/eurheartj\/ehv157.","journal-title":"Eur Heart J"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2018.01.036","volume":"270","author":"A Pelczarska","year":"2018","unstructured":"Pelczarska A, Jakubczyk M, Jakubiak-Lasocka J, Banach M, My\u015bliwiec M, et al. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland. Atherosclerosis. 2018;270:132\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.036.","journal-title":"Atherosclerosis."},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2019.03.016","volume":"143","author":"S Hajighasemi","year":"2019","unstructured":"Hajighasemi S, Mahdavi Gorabi A, Bianconi V, Pirro M, Banach M, et al. A review of gene- and cell-based therapies for familial hypercholesterolemia. Pharmacol Res. 2019;143:119\u201332. https:\/\/doi.org\/10.1016\/j.phrs.2019.03.016.","journal-title":"Pharmacol Res"},{"key":"1335_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.36290\/vnl.2017.005","volume":"63","author":"R \u010ce\u0161ka","year":"2017","unstructured":"\u010ce\u0161ka R, Freiberger T, Susekov AV, Paragh G, Reiner \u017d, et al. ScreenPro FH - screening project for Familial hypercholesterolemia in central, Southern and Eastern Europe: Basic Epidemiology. Vnitr Lek Winter. 2017;63:25\u201330.","journal-title":"Vnitr Lek Winter"},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/CIRCULATIONAHA.116.025158","volume":"25","author":"MJAM Braamskamp","year":"2017","unstructured":"Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman D, Francis GA, et al. Effect of Rosuvastatin on carotid intima-media thickness in children with heterozygous Familial hypercholesterolemia: the CHARON study (hypercholesterolemia in children and adolescents taking Rosuvastatin open label). Circulation. 2017;25:359\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025158.","journal-title":"Circulation."},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2012.02.043","volume":"222","author":"P Caballero","year":"2012","unstructured":"Caballero P, Alonso R, Rosado P, Mata N, Fern\u00e1ndez-Friera L, et al. Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities. Atherosclerosis. 2012;222:468\u201372. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.02.043.","journal-title":"Atherosclerosis."},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.10.001","volume":"213","author":"MH Miname","year":"2010","unstructured":"Miname MH, Ribeiro MS 2nd, Parga Filho J, Avila LF, Bortolotto LA, et al. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. Atherosclerosis. 2010;213:486\u201391. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.10.001.","journal-title":"Atherosclerosis."},{"issue":"16","key":"1335_CR22","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, et al. 20-year follow-up of statins in children with Familial hypercholesterolemia. N Engl J Med. 2019;381(16):1547\u201356. https:\/\/doi.org\/10.1056\/NEJMoa1816454.","journal-title":"N Engl J Med"},{"key":"1335_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2014.05.917","volume":"235","author":"I Narverud","year":"2014","unstructured":"Narverud I, Retterst\u00f8l K, Iversen PO, Halvorsen B, Ueland T, et al. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review. Atherosclerosis. 2014;235:299\u2013309. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.917.","journal-title":"Atherosclerosis."},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1210\/jc.2003-030644","volume":"89","author":"AH Slyper","year":"2004","unstructured":"Slyper AH. Clinical review 168: what vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab. 2004;89:3089\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"199e204. E192","DOI":"10.1016\/j.jpeds.2009.02.022","volume":"155","author":"O Guardamagna","year":"2009","unstructured":"Guardamagna O, Restagno G, Rolfo E, Pederiva C, Martini S, et al. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia. J Pediatr. 2009;155:199e204. E192.","journal-title":"J Pediatr"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"471e5","DOI":"10.1016\/j.atherosclerosis.2009.06.006","volume":"207","author":"O Guardamagna","year":"2009","unstructured":"Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis. 2009;207:471e5.","journal-title":"Atherosclerosis."},{"key":"1335_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","volume":"363","author":"A Wiegman","year":"2004","unstructured":"Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J, et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet. 2004;363:369\u201370.","journal-title":"Lancet."},{"key":"1335_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9150(02)00003-5","volume":"163","author":"S de Jongh","year":"2002","unstructured":"de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJ, et al. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis. 2002;163:193\u20137.","journal-title":"Atherosclerosis."},{"key":"1335_CR29","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1161\/01.ATV.20.9.2070","volume":"20","author":"Y Aggoun","year":"2000","unstructured":"Aggoun Y, Bonnet D, Sidi D, Girardet JP, Brucker E, et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2000;20:2070\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1335_CR30","first-page":"250e7","volume":"40","author":"S Riggio","year":"2010","unstructured":"Riggio S, Mandraffino G, Sardo MA, Iudicello R, Camarada N, et al. Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Investig. 2010;40:250e7.","journal-title":"Eur J Clin Investig"},{"key":"1335_CR31","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/ajh\/hpu034","volume":"27","author":"A Lowenthal","year":"2014","unstructured":"Lowenthal A, Evans JM, Punn R, et al. Arterial applanation tonometry: feasibility and reproducibility in children and adolescents. Am J Hypertens. 2014;27:1218\u201324.","journal-title":"Am J Hypertens"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2015.09.014","volume":"243","author":"I Narverud","year":"2015","unstructured":"Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, et al. Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia. Atherosclerosis. 2015;243:155\u201360. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.09.014.","journal-title":"Atherosclerosis."},{"key":"1335_CR33","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1194\/jlr.M034538","volume":"54","author":"DM Kusters","year":"2013","unstructured":"Kusters DM, Avis HJ, Braamskamp MJ, Huijgen R, Wijburg FA, et al. Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk. J Lipid Res. 2013;54:2543\u20139. https:\/\/doi.org\/10.1194\/jlr.M034538.","journal-title":"J Lipid Res"},{"key":"1335_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/01.STR.0000149936.33498.83","volume":"36","author":"S Moskau","year":"2005","unstructured":"Moskau S, Golla A, Grothe C, Boes M, Pohl C, et al. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke. 2005;36:5\u20138.","journal-title":"Stroke."},{"key":"1335_CR35","doi-asserted-by":"publisher","first-page":"204748731987034","DOI":"10.1177\/2047487319870342","volume":"13","author":"M Banach","year":"2019","unstructured":"Banach M, Penson PE. Genetic testing in familial hypercholesterolaemia: what does it add? Eur J Prev Cardiol. 2019;13:2047487319870342. https:\/\/doi.org\/10.1177\/2047487319870342.","journal-title":"Eur J Prev Cardiol"},{"key":"1335_CR36","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/eurheartj\/ehy527","volume":"21","author":"M Banach","year":"2018","unstructured":"Banach M, Mazidi M, Mikhailidis DP, Toth PP, Jozwiak J, et al. Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey. Eur Heart J. 2018;21:3635\u201340.","journal-title":"Eur Heart J"},{"key":"1335_CR37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1177\/2047487319829746","volume":"26","author":"S Lee","year":"2019","unstructured":"Lee S, Akioyamen LE, Aljenedil S, et al. Genetic testingfor familial hypercholesterolaemia: Impact on diagnosis,treatment and cardiovascular risk. Eur J Prev Cardiol. 2019;26:1262\u201370.","journal-title":"Eur J Prev Cardiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01335-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-020-01335-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01335-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T19:46:41Z","timestamp":1626205601000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01335-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01335-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-19742\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19742\/v2","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the local Bioethical committee (approval number 28\/2016). All the participants\/participants\u2019 guardians signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria. The article is original, has not already been published in a journal, and is not currently under consideration by another journal. We agree to the terms of the BioMed Central Copyright and License Agreement, where applicable, Open Data policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MB - speakers bureau: Abbott\/Mylan, Abbott Vascular, Actavis, Akcea, Amgen, Biofarm, KRKA, MSD, Sanofi-Aventis, Servier and Valeant; consultant to Abbott Vascular, Akcea, Amgen, Daichii Sankyo, Esperion, Lilly, MSD, Resverlogix, Sanofi-Aventis; Grants from Sanofi and Valeant; all other authors have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}